We have located links that may give you full text access.
A 6-year experience with the use of expanded polytetrafluoroethylene in rhinoplasty.
Plastic and Reconstructive Surgery 1998 May
To date, there are few published large series within the literature on the use of expanded polytetrafluoroethylene (Gore-Tex) in rhinoplasty. This retrospective study, based on chart and photographic reviews, serves to contribute a 6-year experience (mean patient follow-up period, 17.5 months) with the alloplast in nasal surgery amassed by one surgeon. The same technique was used in all the 189 patients reviewed, who received 211 procedures. The 189 patients, 44 male and 145 female and from 15 to 70 years of age, were reviewed 3 months to 6 years after Gore-Tex implantation rhinoplasties. The results were assessed according to the follow-up notes in the chart reflecting patients' and surgeon's comments and full preoperative and postoperative photographic documentation. Patient satisfaction was expressed with respect to aesthetic and functional outcome in all cases. Patient impressions were verified by critical assessment during follow-up examination. The implants showed excellent stability and tissue tolerance. Complications requiring removal occurred in 2.7 percent of implants placed. The authors are of the opinion that, in rhinoplasty, with the exception of the nasal tip, columella, or problems in which corrections would require rigidity of the grafted or implanted material, the Gore-Tex alloplast is an excellent alternative to autografts. Nasal tip or columellar sites do not render adequate soft-tissue cover, allowing the implant to rest close to the surgical incision. Because this creates additional risk of implant extrusion, such locations were avoided in the series of patients presented.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app